Drug · DIN 02546035
SUMATRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 29, 2024; first marketed April 29, 2024.
- Drug Identification Number (DIN)
- 02546035
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 8, 2024: NOC 32845Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
Other DINs named SUMATRIPTAN
- DIN 02286521 · Marketed
- DIN 02286548 · Marketed
- DIN 02546043 · Marketed
- DIN 02286513 · Cancelled Post Market
- DIN 02344718 · Cancelled Pre Market
- DIN 02344726 · Cancelled Pre Market
- DIN 02344734 · Cancelled Pre Market
- DIN 02546027 · Approved